糖尿病和脂代谢紊乱及冠心病

被引:18
作者
钱熙国
机构
[1] 新疆医科大学第一附属医院!邮政编码
关键词
糖尿病病人; 脂代谢; 冠心病; 冠状动脉病; 血管并发症;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:248 / 250
页数:3
相关论文
共 9 条
[1]  
Effects of intensiveblood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment(HOT) randomised trial. Hansson L,Zanchetti A,Carruthers SG,et al. The Lancet . 1998
[2]  
Mortality from coronaryheart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocadial infarction. Ha Haffner SM,Lehto S,Ronnemaa T,et al. The New England Journal of Medicine . 1998
[3]  
Cardiovascular eventsand their reduction with pravastation in diabetic and glucose intolerant myocardial infarction survivors with average cholesterol levels. Goldberg RB,Mellles MJ,Sacks FM,et al. Circulation . 1998
[4]  
ADA: Smoking and diabetes. Diabetes Care . 2000
[5]  
The pattern of dyslipidemiaamong urban African-Americans with type 2 diabetes. Cook CB,Erdman DM,Ryan GJ,et al. Diabetes Care . 2000
[6]  
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[7]  
Effects of high doses of simvastatin and atorvastatin on high density lipoprotein cholesterol andapolipoprotein A-1. Crouse JR,Frochlich J,Ose L,et al. The American Journal of Cardiology . 1999
[8]  
Cbolesterol loweringwith simvastatin improves prognosis of diabetic patients with coronary heart disease. Pyorala K,Pedersen TR,Kjekshus J,et al. Diabetes Care . 1997
[9]  
Efficacy and six-month safety ofsimvastatin 80 mg/day: Results from the Worldwide SimvastatinExoanded dose program (WESDP ). l7. Ose L,Kastelein JJP,Scott R,et al. Nutrition Metabolism and Cardiovascular Diseases . 1998